Clinical trial
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy…
NCT00462735 · Johnny Kao, Other · Completed
Key facts
| NCT number | NCT00462735 |
|---|---|
| Title | Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer |
| Official title | Phase II Study of Concomitant Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer |
| Lead sponsor | Johnny Kao, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Cancer of the Pharynx, Cancer of the Larynx, Nose Neoplasms, Paranasal Sinus Neoplasms, Cancer of the Oral Cavity |
| Intervention type | Drug, Procedure |
| Interventions | Cetuximab, Hydroxyurea, Fluorouracil, radiotherapy |
| Enrollment | 33 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Apr 19, 2007 |
| Last update posted | Mar 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: